Theraclion S.A.

Theraclion S.A.

TCLIF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$39.25M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Theraclion S.A.Theraclion S.A.-5.7-3214%--12.5

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$39.25 Million
Enterprise Value$43.17 Million
Earnings per Share$-0.09
Beta0.42
Outstanding Shares73,096,812

Return

Return on Equity3213.58%ROE
Return on Assets-85.87%
Return on Invested Capital-125.89%

Valuation & Multiples

P/E Ratio-5.74P/E Ratio
PEG-14.28PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.53Price to Book Ratio
Enterprise Value to Revenue14.28
Enterprise Value to EBIT-3.25
Enterprise Value to Net Income-4
Total Debt to Enterprise0.11
Debt to Equity-12.52Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
September 16, 2026
EPS
-$0.06
Reported
Revenue
$751,967
Reported

Next Earnings Call

Expected Date
April 29, 2027
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Theraclion S.A.

36 employees
CEO: Martin Deterre

Theraclion SA, established in 2004 and based in Malakoff, France, specializes in developing innovative echotherapy medical solutions. These treatments harness high-intensity focused ultrasound (HIFU) technology. Their offerings include S...

Questions & Answers